解读中国PCI指南2009系列讲座(三) 经皮冠状动脉介入治疗与药物治疗
韩雅玲,徐凯
摘要(Abstract)：
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 韩雅玲,徐凯
参考文献(References)：
- [1]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.经皮冠状动脉介入治疗指南(2009).中华心血管病杂志,2009,37:4-25.
- [2]Boden WE,O'Rourke RA,Teo KK,et al.COURAGE Trial Re-search Group.Optimal medical therapy with or without PCI forstable coronary disease.N Engl J Med,2007,356:1503-1516.
- [3]Shaw LJ,Berman DS,Maron DJ,et al.COURAGE Investiga-tors.Optimal medical therapy with or without percutaneous coro-nary intervention to reduce ischemic burden:results from theClinical Outcomes Utilizing Revascularization and AggressiveDrug Evaluation(COURAGE)trial nuclear substudy.Circula-tion,2008,117:1283-1291.
- [4]Jolly SS,Pogue J,Haladyn K,et al.Effects of aspirin dose onischaemic events and bleeding after percutaneous coronary inter-vention:insights from the PCI-CURE study.Eur Heart J,2009,30:900-907.
- [5]Montalescot G,Sideris G,Meuleman C,et al.ALBIONTrial In-vestigators.A randomized comparison of high clopidogrel loadingdoses in patients with non-ST-segment elevation acute coronarysyndromes:the ALBION(Assessment of the Best Loading Doseof Clopidogrel to Blunt Platelet Activation,Inflammation and On-going Necrosis)trial.J Am Coll Cardiol,2006,48:931-938.
- [6]Cuisset T,Frere C,Quilici J,et al.Benefit of a 600-mg loadingdose of clopidogrel on platelet reactivity and clinical outcomes inpatients with non-ST-segment elevation acute coronary syndromeundergoing coronary stenting.J Am Coll Cardiol,2006,48:1339-1345.
- [7]Mehta SR,Bassand JP,Chrolavicius S,et al.CURRENT-OA-SIS 7 Steering Committee.Design and rationale of CURRENT-OASIS 7:a randomized,2×2 factorial trial evaluating optimaldosing strategies for clopidogrel and aspirin in patients with STand non-ST-elevation acute coronary syndromes managed with anearly invasive strategy.Am Heart J,2008,156:1080-1088.
- [8]Lagerqvist B,James SK,Stenestrand U,et al.SCAAR StudyGroup.Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.N Engl J Med,2007,356:1009-1019.
- [9]James SK,Stenestrand U,Lindback J,et al.SCAAR StudyGroup.Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden.N Engl J Med,2009,360:1933-1945.
- [10]Taylor AJ,Sullenberger LE,Lee HJ,et al.Arterial Biology forthe Investigation of the Treatment Effects of Reducing Cholesterol(ARBITER)2:a double-blind,placebo-controlled study of ex-tended-release niacin on atherosclerosis progression in secondaryprevention patients treated with statins.Circulation,2004,110:3512-3517.
- [11]ADVANCE Collaborative Group,Patel A,MacMahon S,et al.Intensive blood glucose control and vascular outcomes in patientswith type 2 diabetes.N Engl J Med,2008,358:2560-2572.